Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant LH add-on to recombinant FSH plus GnRH antagonist in women older than 35 undergoing IVF/ICSI
NL-OMON29497Not yet recruiting
- Sponsor
- VU University Medical Center, Devision of Reproductive Medicine
- Start
- Jan 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of lutropin alfa, follitropin alfa and cetrorelix in female infertility, sponsored by VU University Medical Center, Devision of Reproductive Medicine. Planned start Jan 2006; status: not yet recruiting.
02
Drugs
lutropin alfafollitropin alfacetrorelix
03
Conditions
female infertility
Beyond the preview
Go deeper on NL-OMON29497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29497.